(Q39202691)

9 September 2017

title

Vaccine prospects of killed but metabolically active Leishmania against visceral leishmaniasis (English)

1 reference

9 September 2017

main subject

visceral leishmaniasis

1 reference

Amrita Das

1

1 reference

9 September 2017

Nahid Ali

series ordinal

2

1 reference

9 September 2017

publication date

1 July 2012

1 reference

Expert Review of Vaccines

9 September 2017

published in

1 reference

9 September 2017

volume

11

1 reference

9 September 2017

issue

7

1 reference

9 September 2017

page(s)

783-785

1 reference

UDP-Gal: N-acetylglucosamine beta 1-4 galactosyltransferase expressing live attenuated parasites as vaccine for visceral leishmaniasis

9 September 2017

cites work

1 reference

Leishmaniasis: current status of vaccine development

21 January 2018

1 reference

Live nonpathogenic parasitic vector as a candidate vaccine against visceral leishmaniasis

21 January 2018

1 reference

Intracellular replication-deficient Leishmania donovani induces long lasting protective immunity against visceral leishmaniasis.

21 January 2018

1 reference

Killed but metabolically active Leishmania infantum as a novel whole-cell vaccine for visceral leishmaniasis

21 January 2018

1 reference

Recombinant Leishmania tarentolae expressing the A2 virulence gene as a novel candidate vaccine against visceral leishmaniasis.

21 January 2018

1 reference

Leishmania mexicanaandLeishmania major:Attenuation of Wild‐Type Parasites and Vaccination with the Attenuated Lines

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1586/ERV.12.50

1 reference

9 September 2017

1 reference